# A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

> **NCT00628680** · PHASE3 · UNKNOWN · sponsor: **Ash Access Technology** · enrollment: 415 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** AAT-023 solution (Zuragen)
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT00628680
- **Lead sponsor:** Ash Access Technology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2008-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00628680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00628680, "A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00628680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*